Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 49.00 points (-0.3%) at 17,934 as of Wednesday, Dec. 31, 2014, 3:25 PM ET. The NYSE advances/declines ratio sits at 1,635 issues advancing vs. 1,400 declining with 160 unchanged.

The Technology sector as a whole closed the day up 0.1% versus the S&P 500, which was down 0.7%. Top gainers within the Technology sector included LookSmart ( LOOK), up 2.2%, GRAVITY ( GRVY), up 1.7%, One Horizon Group ( OHGI), up 1.6%, CounterPath ( CPAH), up 6.2% and CollabRx ( CLRX), up 5.3%.

TheStreet Ratings Group would like to highlight 3 stocks pushing the sector higher today:

CollabRx ( CLRX) is one of the companies that pushed the Technology sector higher today. CollabRx was up $0.03 (5.3%) to $0.60 on heavy volume. Throughout the day, 52,835 shares of CollabRx exchanged hands as compared to its average daily volume of 21,900 shares. The stock ranged in a price between $0.56-$0.64 after having opened the day at $0.56 as compared to the previous trading day's close of $0.57.

CollabRx, Inc. provides cloud-based expert systems to inform healthcare decision-making. The company's cloud-based expert systems provide clinical knowledge to institutions, physicians, researchers, and patients for genomics-based medicine in cancer. CollabRx has a market cap of $1.7 million and is part of the internet industry. Shares are down 85.0% year-to-date as of the close of trading on Tuesday. Currently there is 1 analyst who rates CollabRx a buy, no analysts rate it a sell, and none rate it a hold.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings rates CollabRx as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself.

Highlights from TheStreet Ratings analysis on CLRX go as follows:

  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Health Care Technology industry. The net income has significantly decreased by 80.5% when compared to the same quarter one year ago, falling from -$0.56 million to -$1.02 million.
  • Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness within the corporation. Compared to other companies in the Health Care Technology industry and the overall market, COLLABRX INC's return on equity significantly trails that of both the industry average and the S&P 500.
  • Net operating cash flow has decreased to -$0.92 million or 46.32% when compared to the same quarter last year. In addition, when comparing to the industry average, the firm's growth rate is much lower.
  • CLRX's stock share price has done very poorly compared to where it was a year ago: Despite any rallies, the net result is that it is down by 85.00%, which is also worse that the performance of the S&P 500 Index. Investors have so far failed to pay much attention to the earnings improvements the company has managed to achieve over the last quarter. Naturally, the overall market trend is bound to be a significant factor. However, in one sense, the stock's sharp decline last year is a positive for future investors, making it cheaper (in proportion to its earnings over the past year) than most other stocks in its industry. But due to other concerns, we feel the stock is still not a good buy right now.
  • The revenue fell significantly faster than the industry average of 21.0%. Since the same quarter one year prior, revenues fell by 29.9%. The declining revenue has not hurt the company's bottom line, with increasing earnings per share.

You can view the full analysis from the report here: CollabRx Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

At the close, CounterPath ( CPAH) was up $0.03 (6.2%) to $0.56 on average volume. Throughout the day, 27,919 shares of CounterPath exchanged hands as compared to its average daily volume of 22,900 shares. The stock ranged in a price between $0.56-$0.62 after having opened the day at $0.58 as compared to the previous trading day's close of $0.53.

CounterPath has a market cap of $24.7 million and is part of the internet industry. Shares are down 50.4% year-to-date as of the close of trading on Tuesday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

LookSmart ( LOOK) was another company that pushed the Technology sector higher today. LookSmart was up $0.02 (2.2%) to $0.68 on heavy volume. Throughout the day, 26,808 shares of LookSmart exchanged hands as compared to its average daily volume of 12,600 shares. The stock ranged in a price between $0.68-$0.70 after having opened the day at $0.69 as compared to the previous trading day's close of $0.67.

LookSmart, Ltd. provides search and display advertising network solutions in the United States, Europe, the Middle East, and Africa. LookSmart has a market cap of $4.6 million and is part of the internet industry. Shares are down 67.3% year-to-date as of the close of trading on Tuesday. Currently there are no analysts who rate LookSmart a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates LookSmart as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, disappointing return on equity and generally disappointing historical performance in the stock itself.

Highlights from TheStreet Ratings analysis on LOOK go as follows:

  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Internet Software & Services industry. The net income has significantly decreased by 36.8% when compared to the same quarter one year ago, falling from -$0.95 million to -$1.30 million.
  • Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness within the corporation. Compared to other companies in the Internet Software & Services industry and the overall market, LOOKSMART LTD's return on equity significantly trails that of both the industry average and the S&P 500.
  • Despite any intermediate fluctuations, we have only bad news to report on this stock's performance over the last year: it has tumbled by 61.98%, worse than the S&P 500's performance. Consistent with the plunge in the stock price, the company's earnings per share are down 27.77% compared to the year-earlier quarter. Naturally, the overall market trend is bound to be a significant factor. However, in one sense, the stock's sharp decline last year is a positive for future investors, making it cheaper (in proportion to its earnings over the past year) than most other stocks in its industry. But due to other concerns, we feel the stock is still not a good buy right now.
  • LOOKSMART LTD's earnings per share declined by 27.8% in the most recent quarter compared to the same quarter a year ago. This company has not demonstrated a clear trend in earnings over the past 2 years, making it difficult to accurately predict earnings for the coming year. During the past fiscal year, LOOKSMART LTD continued to lose money by earning -$0.93 versus -$1.92 in the prior year.
  • The revenue fell significantly faster than the industry average of 28.8%. Since the same quarter one year prior, revenues fell by 20.1%. The declining revenue appears to have seeped down to the company's bottom line, decreasing earnings per share.

You can view the full analysis from the report here: LookSmart Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

More from Markets

Fossil Shares Rise After Company Announces Plan to Sell Tech to Google

Fossil Shares Rise After Company Announces Plan to Sell Tech to Google

Netflix Shares Fall After Company Reports Mixed Earnings Results

Netflix Shares Fall After Company Reports Mixed Earnings Results

3 Things to Know at the Market Close: Bank Earnings, GDP Report and Jim Cramer

3 Things to Know at the Market Close: Bank Earnings, GDP Report and Jim Cramer

Morgan Stanley Sinks as Profit Misses Estimates Amid Trading Slump

Morgan Stanley Sinks as Profit Misses Estimates Amid Trading Slump

IBM to Run Vodafone's Cloud Business, Offer Solutions to Its European Customers

IBM to Run Vodafone's Cloud Business, Offer Solutions to Its European Customers